BTN3A1 and sarcoma: In datasets based on RNA‐seq (Fig. 2B), higher expression of BTN3A1 was associated with better prognosis in bladder urothelial carcinoma (BLCA), rectum adenocarcinoma (READ), sarcoma (SARC), and UCEC.